vs
HARROW, INC.（HROW）与REPUBLIC BANCORP INC（RBCAA）财务数据对比。点击上方公司名可切换其他公司
REPUBLIC BANCORP INC的季度营收约是HARROW, INC.的1.1倍（$94.3M vs $89.1M），REPUBLIC BANCORP INC净利率更高（24.2% vs 7.4%，领先16.8%），HARROW, INC.同比增速更快（33.3% vs 5.3%），REPUBLIC BANCORP INC自由现金流更多（$161.1M vs $8.1M），过去两年HARROW, INC.的营收复合增速更高（60.5% vs -11.5%）
哈罗健康（前身为Imprimis制药）是一家上市制药企业，总部位于美国田纳西州纳什维尔，深耕制药领域相关业务，在医药研发、生产及商业化方面拥有成熟的运营体系，产品及服务覆盖多个医疗需求场景。
肯塔基州共和银行是美国的一家区域性银行控股企业，提供零售及商业银行全品类服务，涵盖个人存贷款、企业融资、按揭产品及财富管理解决方案，主要服务肯塔基州及周边州的个人消费者和中小企业客户。
HROW vs RBCAA — 直观对比
营收规模更大
RBCAA
是对方的1.1倍
$89.1M
营收增速更快
HROW
高出28.0%
5.3%
净利率更高
RBCAA
高出16.8%
7.4%
自由现金流更多
RBCAA
多$153.0M
$8.1M
两年增速更快
HROW
近两年复合增速
-11.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $89.1M | $94.3M |
| 净利润 | $6.6M | $22.8M |
| 毛利率 | 79.3% | — |
| 营业利润率 | 17.5% | 29.3% |
| 净利率 | 7.4% | 24.2% |
| 营收同比 | 33.3% | 5.3% |
| 净利润同比 | -2.2% | 20.0% |
| 每股收益（稀释后） | $0.20 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HROWRBCAA
| Q4 25 | $89.1M | $94.3M | ||
| Q3 25 | $71.6M | $93.5M | ||
| Q2 25 | $63.7M | $93.8M | ||
| Q1 25 | $47.8M | $135.8M | ||
| Q4 24 | $66.8M | $89.5M | ||
| Q3 24 | $49.3M | $88.1M | ||
| Q2 24 | $48.9M | $86.9M | ||
| Q1 24 | $34.6M | $120.3M |
净利润HROWRBCAA
| Q4 25 | $6.6M | $22.8M | ||
| Q3 25 | $1.0M | $29.7M | ||
| Q2 25 | $5.0M | $31.5M | ||
| Q1 25 | $-17.8M | $47.3M | ||
| Q4 24 | $6.8M | $19.0M | ||
| Q3 24 | $-4.2M | $26.5M | ||
| Q2 24 | $-6.5M | $25.2M | ||
| Q1 24 | $-13.6M | $30.6M |
毛利率HROWRBCAA
| Q4 25 | 79.3% | — | ||
| Q3 25 | 75.3% | — | ||
| Q2 25 | 74.5% | — | ||
| Q1 25 | 67.5% | — | ||
| Q4 24 | 78.8% | — | ||
| Q3 24 | 75.6% | — | ||
| Q2 24 | 74.4% | — | ||
| Q1 24 | 69.5% | — |
营业利润率HROWRBCAA
| Q4 25 | 17.5% | 29.3% | ||
| Q3 25 | 20.6% | 40.4% | ||
| Q2 25 | 17.9% | 43.0% | ||
| Q1 25 | -23.5% | 44.1% | ||
| Q4 24 | 19.3% | 25.8% | ||
| Q3 24 | 2.7% | 38.4% | ||
| Q2 24 | 3.1% | 37.0% | ||
| Q1 24 | -20.0% | 32.2% |
净利率HROWRBCAA
| Q4 25 | 7.4% | 24.2% | ||
| Q3 25 | 1.4% | 31.8% | ||
| Q2 25 | 7.8% | 33.5% | ||
| Q1 25 | -37.2% | 34.8% | ||
| Q4 24 | 10.1% | 21.2% | ||
| Q3 24 | -8.6% | 30.1% | ||
| Q2 24 | -13.2% | 29.0% | ||
| Q1 24 | -39.2% | 25.4% |
每股收益（稀释后）HROWRBCAA
| Q4 25 | $0.20 | — | ||
| Q3 25 | $0.03 | — | ||
| Q2 25 | $0.13 | — | ||
| Q1 25 | $-0.50 | — | ||
| Q4 24 | $0.19 | — | ||
| Q3 24 | $-0.12 | — | ||
| Q2 24 | $-0.18 | — | ||
| Q1 24 | $-0.38 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $72.9M | $220.0M |
| 总债务越低越好 | $250.0M | — |
| 股东权益账面价值 | $52.4M | $1.1B |
| 总资产 | $399.5M | $7.0B |
| 负债/权益比越低杠杆越低 | 4.77× | — |
8季度趋势，按日历期对齐
现金及短期投资HROWRBCAA
| Q4 25 | $72.9M | $220.0M | ||
| Q3 25 | $74.3M | $484.2M | ||
| Q2 25 | $53.0M | $484.8M | ||
| Q1 25 | $66.7M | $793.0M | ||
| Q4 24 | $47.2M | $432.2M | ||
| Q3 24 | $72.6M | $530.9M | ||
| Q2 24 | $71.0M | $400.1M | ||
| Q1 24 | $76.0M | $546.4M |
总债务HROWRBCAA
| Q4 25 | $250.0M | — | ||
| Q3 25 | $347.2M | — | ||
| Q2 25 | $250.6M | — | ||
| Q1 25 | $256.9M | — | ||
| Q4 24 | $262.7M | — | ||
| Q3 24 | $230.7M | — | ||
| Q2 24 | $236.3M | — | ||
| Q1 24 | $243.4M | — |
股东权益HROWRBCAA
| Q4 25 | $52.4M | $1.1B | ||
| Q3 25 | $47.0M | $1.1B | ||
| Q2 25 | $49.7M | $1.1B | ||
| Q1 25 | $56.5M | $1.0B | ||
| Q4 24 | $69.7M | $992.0M | ||
| Q3 24 | $58.0M | $979.7M | ||
| Q2 24 | $58.5M | $955.4M | ||
| Q1 24 | $60.6M | $935.6M |
总资产HROWRBCAA
| Q4 25 | $399.5M | $7.0B | ||
| Q3 25 | $363.1M | $7.0B | ||
| Q2 25 | $345.0M | $7.0B | ||
| Q1 25 | $364.2M | $7.1B | ||
| Q4 24 | $389.0M | $6.8B | ||
| Q3 24 | $351.5M | $6.7B | ||
| Q2 24 | $306.6M | $6.6B | ||
| Q1 24 | $295.5M | $6.9B |
负债/权益比HROWRBCAA
| Q4 25 | 4.77× | — | ||
| Q3 25 | 7.39× | — | ||
| Q2 25 | 5.05× | — | ||
| Q1 25 | 4.55× | — | ||
| Q4 24 | 3.77× | — | ||
| Q3 24 | 3.98× | — | ||
| Q2 24 | 4.04× | — | ||
| Q1 24 | 4.02× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $8.4M | $168.2M |
| 自由现金流经营现金流 - 资本支出 | $8.1M | $161.1M |
| 自由现金流率自由现金流/营收 | 9.1% | 170.9% |
| 资本支出强度资本支出/营收 | 0.4% | 7.5% |
| 现金转化率经营现金流/净利润 | 1.27× | 7.37× |
| 过去12个月自由现金流最近4个季度 | $43.0M | $288.6M |
8季度趋势，按日历期对齐
经营现金流HROWRBCAA
| Q4 25 | $8.4M | $168.2M | ||
| Q3 25 | $16.6M | $33.3M | ||
| Q2 25 | $-803.0K | $8.4M | ||
| Q1 25 | $19.7M | $93.2M | ||
| Q4 24 | $-17.8M | $149.0M | ||
| Q3 24 | $3.0M | $51.3M | ||
| Q2 24 | $-2.7M | $4.0M | ||
| Q1 24 | $-4.6M | $71.2M |
自由现金流HROWRBCAA
| Q4 25 | $8.1M | $161.1M | ||
| Q3 25 | $16.4M | $30.8M | ||
| Q2 25 | $-969.0K | $5.2M | ||
| Q1 25 | $19.5M | $91.6M | ||
| Q4 24 | $-18.3M | $143.2M | ||
| Q3 24 | $2.3M | $49.8M | ||
| Q2 24 | $-3.1M | $2.7M | ||
| Q1 24 | $-4.7M | $69.1M |
自由现金流率HROWRBCAA
| Q4 25 | 9.1% | 170.9% | ||
| Q3 25 | 22.9% | 32.9% | ||
| Q2 25 | -1.5% | 5.5% | ||
| Q1 25 | 40.8% | 67.4% | ||
| Q4 24 | -27.4% | 160.0% | ||
| Q3 24 | 4.8% | 56.5% | ||
| Q2 24 | -6.3% | 3.1% | ||
| Q1 24 | -13.6% | 57.5% |
资本支出强度HROWRBCAA
| Q4 25 | 0.4% | 7.5% | ||
| Q3 25 | 0.3% | 2.6% | ||
| Q2 25 | 0.3% | 3.5% | ||
| Q1 25 | 0.4% | 1.2% | ||
| Q4 24 | 0.8% | 6.5% | ||
| Q3 24 | 1.2% | 1.7% | ||
| Q2 24 | 0.7% | 1.5% | ||
| Q1 24 | 0.3% | 1.7% |
现金转化率HROWRBCAA
| Q4 25 | 1.27× | 7.37× | ||
| Q3 25 | 16.26× | 1.12× | ||
| Q2 25 | -0.16× | 0.27× | ||
| Q1 25 | — | 1.97× | ||
| Q4 24 | -2.62× | 7.84× | ||
| Q3 24 | — | 1.93× | ||
| Q2 24 | — | 0.16× | ||
| Q1 24 | — | 2.33× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
